Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis

Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis

Individuals with cystic fibrosis (CF) are given antimicrobials as prophylaxis against bacterial lung infection, which contributes to the growing emergence of multidrug resistant (MDR) pathogens isolated. Pathogens such as Pseudomonas aeruginosa that are commonly isolated from individuals with CF are...

Full description

Bibliographic Details
Main Authors: Renee N. Ng, Anna S. Tai, Barbara J. Chang, Stephen M. Stick, Anthony Kicic
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Microbiology
Subjects:
bacteriophage
cystic fibrosis
lung disease
alternative therapy
animal models
antimicrobials
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2020.593988/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2020.593988/full

Similar Items